Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
cancer
cancer drugs
clinical trials
national top stories
san francisco top stories
blueprint medicines
eli lilly
non-small cell lung cancer
roche
avapritinib
boston
deals
europe blog main
fda
genentech
investing
ipo
medullary thyroid cancer
pralsetinib
revolution medicines
san francisco
sanofi
selpercatinib
the column group
third rock ventures
thyroid cancer
warp drive bio
amgen
black diamond therapeutics
bladder cancer
capmatinib
cobimetinib
colorectal cancer
cstone pharmaceuticals
What
cancer
5
×
medicines
5
×
drug
ipo
research
approval
blueprint
fda
proteins
ret
revolution
targets
address
approves
biotech
black
cancer’s
candidate
carries
certain
clinic
companies
currently
designed
despite
diamond
disease
eluded
family
frontiers
genetic
hardest
hit
hopes
hottest
hunters
known
latest
lead
leading
Language
unset
Current search:
biotech
×
medicines
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic